Heterogeneity in age of onset of colorectal cancer in individuals with mutations in DNA mismatch repair genes (Lynch syndrome) suggests the influence of other lifestyle and genetic modifiers. We hypothesized that genes regulating the cell cycle influence the observed heterogeneity as cell cycle-related genes respond to DNA damage by arresting the cell cycle to provide time for repair and induce transcription of genes that facilitate repair. We examined the association of 1456 single nucleotide polymorphisms (SNPs) in 128 cell cycle-related genes and 31 DNA repair-related genes in 485 non-Hispanic white participants with Lynch syndrome to determine whether there are SNPs associated with age of onset of colorectal cancer. Genotyping was performed on an Illumina GoldenGate platform, and data were analyzed using Kaplan-Meier survival analysis, Cox regression analysis and classification and regression tree (CART) methods. Ten SNPs were independently significant in a multivariable Cox proportional hazards regression model after correcting for multiple comparisons (P < 5 × 10 -4 ). Furthermore, risk modeling using CART analysis defined combinations of genotypes for these SNPs with which subjects could be classified into low-risk, moderate-risk and high-risk groups that had median ages of colorectal cancer onset of 63, 50 and 42 years, respectively. The age-associated risk of colorectal cancer in the high-risk group was more than four times the risk in the low-risk group (hazard ratio = 4.67, 95% CI = 3.16-6.92). The additional genetic markers identified may help in refining risk groups for more tailored screening and follow-up of non-Hispanic white patients with Lynch syndrome.
Introduction
Lynch syndrome (also called hereditary non-polyposis colorectal cancer) is an autosomal dominant inherited cancer predisposition disorder. It is caused by defects in DNA mismatch repair (MMR) due to mutations in DNA MMR genes-MLH1, MSH2, MSH6 and PMS2 (1) (2) (3) (4) and more recently also due to mutations in TACSTD1 (or EPCAM) (5, 6) . The cancers most commonly seen in affected individuals are early onset colorectal cancer (CRC) and endometrial cancer, but cancers of other sites are also observed, such as cancers of the stomach, biliary tract, pancreas, kidneys, brain and skin (7, 8) . Lynch syndrome tumors are characterized by microsatellite instability resulting from deficient DNA MMR and also demonstrate loss of staining for one or more of the MMR proteins (9) (10) (11) . These tumor characteristics are key in suspecting Lynch syndrome in an individual and form the basis for genetic testing for Lynch syndrome.
Although mutations in DNA MMR genes are the underlying cause of Lynch syndrome, there is heterogeneity in expression of the cancer phenotype, suggesting that other genetic and lifestyle factors may influence cancer risk. The heterogeneity is particularly evident in the variability in age of onset of CRC seen in these patients. Carriers of MSH6 mutations have a later age of CRC onset than MLH1 and MSH2 mutation carriers, and CRC is less frequent in MSH6 mutation carriers (12, 13) but mutations in the different MMR genes only account for some of the variability observed in age of onset of CRC.
Cell cycle checkpoints respond to DNA damage by arresting the cell cycle to provide time for repair and by inducing transcription of genes that facilitate repair (14) . Checkpoint loss and perturbation of cell cycle control results in genomic instability and is a hallmark of cancer. More subtle genetic changes due to functional polymorphisms in cell cycle-related genes can act as genetic risk modifiers for the development of cancer. Our previous studies indicate that polymorphisms in the cell cycle-related genes cyclin D1, p53 and AURKA are associated with earlier age of onset of CRC in MMR gene mutation carriers (15) (16) (17) . Other cell cycle-related genes have also been implicated in modifying cancer risk, including p16 (18) , p15 and Rb1 (19) , p21 (19) , p27 (20) and CHEK2 (21) . We hypothesized that in addition to genes regulating MMR, genes regulating the cell cycle influence the heterogeneity in CRC age of onset in patients with Lynch syndrome. To test our hypothesis, we examined the association of 1456 single nucleotide polymorphisms (SNPs) in 128 cell cycle-related genes and 31 DNA repair-related genes in 485 non-Hispanic white subjects with Lynch syndrome to determine whether one or more of the SNPs modified the age-associated risk of CRC. The overarching goal of our study was to provide a better understanding of the role of multiple genetic variants in cell cycle-related genes as risk factors responsible for variation in onset age of Lynch syndrome.
To capture the combined effect of multiple SNPs in the cell cycle pathway, we used a pathways-based genotyping approach, which may amplify the effects of individual polymorphisms that interact in the same pathway and enhance the predictive power. In addition, we utilized a tree-based statistical approach to identify genetic risk factors influencing age-associated risk for Lynch syndrome. We selected a tree-based analysis because it is often able to uncover complex interactions between predictors that may be difficult or impossible to uncover using traditional multivariate techniques. Furthermore, treebased modeling is adept in uncovering predictors that may be largely operative within specific patient subgroups, but may have minimal effect or none in other patient subgroups.
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associated with specific function. It combines literature mining with data on functional classification of genes by the Gene Ontology database. First, a list of key words describing the specific gene function needs to be identified. We used  cell cycle, cycle progression, cycle arrest, cell cycle progression, cell cycle  arrest, cycle regulation, cycle control, cell cycle regulation, cell cycle control,  cell cycle checkpoint, cycle checkpoint, cell cycle checkpoint control, checkpoint and checkpoint control as key words to identify cell cycle-related genes. KnowledgeNet provides a ranking of genes with confidence scores, which we used to prioritize. We next used Ingenuity Pathways Analysis software (Ingenuity Systems, www.ingenuity.com) to search the cell cycle pathway in the Ingenuity Pathways Analysis library of canonical pathways. Genes that appeared on the list identified by searching KnowledgeNet but did not appear within the Ingenuity Pathway Analysis cell cycle pathway were excluded from the list. From the remaining genes, we chose to study the top 124 genes ranked by KnowledgeNet using the cutoff confidence score >0.04.
To further refine the list, we used the KnowledgeNet algorithm to select genes that are considered to be important for colorectal cancer. 
In silico tools for examining functional relevance of SNPs
We explored the functional consequences of the SNPs using two searchable databases F-SNP (http://compbio.cs.queensu.ca/F-SNP/) (24) and the UCSC Genome browser (http://genome.ucsc.edu/cgi-bin/hgTracks) (25, 26) . The UCSC Genome browser incorporates visualization of some of the Encyclopedia of DNA elements (ENCODE) functional elements, such as regions of transcription, transcription factor association, chromatin structure and histone modification (27) .
Statistical methods
The outcome variable for the analysis was time to CRC onset. The data were explored for differences in CRC age of onset by sex and MMR mutation type using the log-rank test. Hazard ratios (HRs) and 95% CIs were generated using Cox proportional hazards regression analysis to test the association of each of the 1456 SNPs with risk of CRC. All association analyses were adjusted for sex and MMR mutation type, and to allow for correlation between CRC onset age between multiple family members, we applied the Huber-White robust variance correction and clustered on the family ID (28) . STATA software (version 10, StataCorp LP, College Station, TX) was used to perform the analyses.
Principal components analysis was conducted to evaluate the potential effects of population structure between Australian and US samples. There was no significant difference in eigenvector loadings for the first five factors showing that Australian-USA differences in structure were a minor source of population variability. Therefore, we did not condition the analysis on study site.
The analyses were performed in five stages, as follows:
Single SNP association analysis with genotypes coded as 0 = wild-type, 1 = heterozygous and 2 = homozygous variant. The models were additive (continuous effect of increasing number of variant alleles 0 versus 1 versus 2), dominant (0 versus 1 and 2), recessive (0, 1 versus 2) and genotypic (0 versus 1, 0 versus 2). All stage 1 Cox regression analyses were adjusted for sex, MMR mutation type and familial correlation. Stage 2: SNPs that were significant in one or more of the genetic models were ranked by their smallest P value. To limit the probability of false-positives due to multiple testing, a false discovery rate method of Benjamini and Hochberg (29) was used to calculate q-value. A false discovery rate cutoff of 0.05 was applied to select the top SNPs, which limited the probability of false-positives due to multiple tests that were carried out. P values for 14 SNPs exceeded the false discovery rate cutoff. The multistage approach allowed us to thoroughly interrogate the association signals and identify clinically meaningful risk groups.
Results
The study sample consisted of 205 men and 280 women from 272 families. All participants were self-reported non-Hispanic Whites. A majority of the subjects had mutations in MLH1 (44.9%) or MSH2 (49.5%), but 27 subjects (5.6%) had MSH6 mutations (Table I) . A majority of the families (66.2%) had only one family member in the study, but the study also included families with two family members (accounting for 14.0% of families), three family members (10.3%) or four or more family members (9.5%). The median age at CRC diagnosis was older in women (58 years) than in men (48 years; logrank test P = 0.0002), and women had a lower rate of CRC diagnosis (Table I) . Similarly, the median age at CRC diagnosis was older in MSH6 mutation carriers (66 years) than in carriers of mutations in MLH1 (48 years) or MSH2 (52 years), and MSH6 mutation carriers had a lower rate of CRC diagnosis (Table I) . There were 191 SNPs associated with age at diagnosis of CRC at P < 0.05 in the adjusted Cox regression analysis, adjusting for sex, mutation type and familial correlation due to presence of multiple family members in the sample. Fourteen SNPs in 13 genes remained significant after correction for multiple comparisons (results in Table  II ). None of the 14 SNPs violated Hardy-Weinberg equilibrium. In the Cox forward-selection regression model, four SNPs on chromosome 5 (CDC25C: rs17171794; KDM3B/FAM53C: rs3734168; CDC25C: rs6874130 and SKP2: rs3804439) were no longer significant at P < 0.05; these SNPs were not included in the multivariable model. Three of the four SNPs that dropped out of the model, rs17171794, rs3734168 and rs6874130, were in high LD with rs3734166 (r 2 ≥ 60) as seen in a LD plot generated using Haploview (30) (Supplementary Figure 1 , available at Carcinogenesis Online) and were likely dropped from the model because of being correlated with rs3734166. The remaining 10 SNPs in 10 genes were significant in the multivariable model, suggesting independent effects on age of CRC onset.
As 10 genes independently influenced age-associated CRC risk, we performed combined analysis according to the number of unfavorable (risk increasing) genotypes carried by each individual with the underlying hypothesis that people with a larger number of unfavorable genotypes would be at higher risk for developing CRC at a younger age. Although single SNPs may confer relatively low risk individually, it has been shown that a panel of SNPs in the same pathway may significantly amplify the effects of individual SNPs (31) (32) (33) . Unfavorable genotypes were classified on the basis of the genetic model that attained significance in the Cox regression. For example, if a SNP was significant in a recessive model, the homozygous variant genotype was considered unfavorable, whereas if the SNP was significant in a dominant model, the heterozygous and the homozygous variant genotypes were as the reference group, people carrying one or two unfavorable genotypes had more than twice the risk and those carrying three or more unfavorable genotypes had more than four times the risk of CRC (Table III) after adjusted for sex, type of MMR mutation and familial correlation. The median age at onset differed significantly between the three groups: it was 58 years for people with no unfavorable genotypes, 48 years for those with 1-2 unfavorable genotypes and 40 years for those with three or more unfavorable genotypes (Figure 1 ).
CART analysis was performed using genotypes of the 10 SNPs, sex and MMR mutation type. The final resulting tree is shown in Figure 2 . There was an initial split on KIF20A: rs10038448. (Table IV) . The log-rank test (P = 4.81 × 10 -14 ) demonstrated a statistically significant difference among the time-to-onset curves of these three groups (Figure 2 ). The median age at onset was 42 years for the high-risk group, 50 years for the moderate-risk group and 63 years for the low-risk group.
Discussion
In this hypothesis-generating study, we identified 10 SNPs significantly associated with age-associated risk of CRC after correction for multiple comparisons. We used a pathways-based multigenic approach to capture the combined effect of multiple SNPs in the cell cycle pathway. The analysis showed evidence of a significant genedosage effect. People with a larger number of unfavorable genotypes were at higher risk. Furthermore, CART analysis identified a subgroup with high probability of cancer occurrence at younger ages, a median CRC onset age of 42 years as well as a subgroup with the later age of onset, a median CRC onset age of 63 years.
The genes associated with the 10 significant SNPs were XRCC5, TTC28, TNF, TGFB1, PPP2R2B, BCL2, KIF20A, CHFR, CDC25C and ATM. These genes are all directly or indirectly involved in cell cycle checkpoint control based on Ingenuity canonical pathways (Ingenuity® Systems, www.ingenuity.com) (Supplementary Figure 2 , available at Carcinogenesis Online).
Many of the significant SNPs in these genes are potentially functional as they are in the 5′ or 3′ untranslated region (UTR) or in the coding region. The SNP rs1051685 is located in the 3′ UTR region of XRCC5 and may be of functional relevance because it is located in an exonic splice enhancer sequence as determined by PupaSNP (35) . The SNP rs12980942 is located in the upstream 5′ UTR of TGFB1 and may affect mRNA stability and translation. TGFB1 plays a critical role in regulation of cell proliferation, differentiation and apoptosis and serves as a tumor suppressor in normal intestinal epithelium (36) . The SNPs rs3734166 and rs1800057 are located in the coding regions of CDC25C and ATM, respectively. CDC25C is a phosphatase that serves as a regulator of G 2 /M transition and mediates this checkpoint in response to DNA damage. The non-synonymous SNP rs3734166 (CDC25C R70C) was significantly associated with early age of onset of CRC in our study. ATM-and Chk1/2-mediated phosphorylation of CDC25C plays a major role in G 2 /M arrest. Our study also found that SNP rs1800057 in ATM, resulting in the amino acid change P1045R, was associated with early age of onset of CRC. The SNP was predicted to be deleterious. Heterozygosity for P1054R is associated with decreased ATM expression in tumors (37) . The SNP is in complete LD with SNP rs1800056: F858L. The two SNPs were reported to be associated with risk of CRC (38) . ATM is critical for regulation of cell cycle checkpoints. Activation of ATM by DNA damage leads to ATM-dependent phosphorylation of CHEK2. Unfavorable genotypes: PPP2R2B: rs10477307 AA, KIF20A: rs10038448 GG, TGFB1/CCDC97: rs12980942 AA, CDC25C: rs3734166 AA, XRCC5: rs1051685 GG, TNF: rs3093662 AG+GG, BCL2: rs1531697 AA, TTC28: rs9608696 GG, CHFR: rs11610954 CT+TT, ATM: rs1800057 CG. Fig. 1 . Kaplan-Meier estimates of age at CRC onset by number of unfavorable genotypes.
Fig. 2. (A)
Time-to-onset tree for age of onset of CRC. Inside each node is the number of affected CRC patients/the total number of subjects. WW, wildtype; WM, heterozygote; MM, homozygous polymorphism; (B) KaplanMeier curves for age of CRC onset by risk groups defined by CART. *See Figure 2 for nodes.
The remaining SNPs that we identified were located in the intronic regions of genes. Recently, the Encyclopedia of DNA elements (ENCODE) project has reported that 80% of the genome is related to some biochemical function after systematically mapping regions of transcription, transcription factor association, chromatin structure and histone modification (27) . We found that many of the intronic SNPs mapped to areas of histone modification (modification of histone proteins present in chromatin influence gene expression by changing how accessible the chromatin is to transcription), DNaseI hypersensitivity clusters (DNase hypersensitivity sites map to regions believed to contain regulatory elements, including CpG islands, and highly conserved sequences) (39) , and altered transcription factor binding sites. SNPs that were predicted to alter a transcription factor binding site using the in silico tool TFSearch (http://www.cbrc.jp/research/db/TFSEARCH. html) included rs12980942 (5′UTR of TGFB1), rs1051685 (3′ UTR of XRCC5), rs3093662 (intronic of TNF and 3′ of LTA) and rs6874130 (CDC25C). In particular, the A-to-G base change of rs3093662 was predicted to gain a cytidine diphosphate binding site; cytidine diphosphate is a transcription regulator known to be involved in cellular proliferation and cell cycle progression (40, 41) , which are key processes in carcinogenesis. Using the UCSC Genome browser (http://genome. ucsc.edu/cgi-bin/hgTracks), intronic SNPs related to areas of histone modification included rs10477307 (PP2R2B), rs12980942 (5′UTR of TGFB1), rs1051685 (3′ UTR of XRCC5) and rs1531697 (BCL2) and some of these SNPS (rs10477307, rs12980942, rs1051685, rs3093662, rs1531697 and rs6874130) were also related to DNaseI hypersensitivity sites. Although intronic, many of these SNPs may therefore influence gene function. Alternatively, the significant SNPs located in intron regions of genes may be linked to other causal SNPs to affect gene activity. In addition, some of the SNPs that we found to be significantly associated with age-associated risk of CRC were associated with susceptibility to other cancers or diseases. For example, SNP rs1051685 in XRCC5 has been reported to be associated with susceptibility to myeloma (35) . SNP rs12980942, in the upstream 5′ UTR of TGFB1, has been reported to be associated with increased susceptibility to asthma (42) . SNP rs1800057 in ATM has been found to be associated with increased risk of prostate cancer and breast cancer and to modify the effect of radiotherapy (43) (44) (45) (46) (47) .
When we performed combined analysis for all 10 significant SNPs, we found that people with a larger number of unfavorable genotypes were at higher risk. Our findings suggest a cumulative effect of SNPs that interact in the same pathway on age-associated risk of CRC.
The CART analysis identified a few subgroups with higher risk of early onset CRC. There was an initial split on KIF20A: rs10038448, suggesting that this variation was one of the most important risk factors for CRC. SNP rs10038448 was selected as a tagging SNP for cell cycle gene CDC23 and is in complete LD with SNP rs2864, which is located in the 3′ UTR of CDC23. CDC23 is a protein essential for cell cycle progression through the G 2 /M transition. CDC23 is a component of the anaphase-promoting complex required for degrading mitotic cyclins and other cell cycle regulators (48). Wang et al. (49) reported that mutant human CDC23 protein decreased cell cycle progression of colon epithelial cells and was involved in expression of human Cyclin b1 protein. The tree shown in Figure 2 may provide some clues regarding how genes act together on the age-associated risk of CRC in patients with Lynch syndrome. As shown in the figure, TGFB1: rs12980942, BCL2: rs1531697 and CHFR: rs11610954 act together. TGFB1 is a well-known cell cycle inhibitor. BCL2 family proteins regulate and contribute to programmed cell death or apoptosis. It has been reported that TGFB1 elevates the protein content of the apoptosis-preventing BCL2 (50) , and BCL2 plays a crucial role in regulating the G 1 /S transition of hematopoietic cells induced by TGFB1 (51) . Checkpoint with forkhead and ring finger domains (CHFR) functions as an important checkpoint protein early in the G 2 /M transition, and its activation delays entry into metaphase in response to mitotic stress (52) . The tree in Figure 2 showed that the TNF gene was also a risk factor for CRC. The TNF gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. Human TNF protein was reported to increase the arrest in G 1 phase of MV-4-11 and MCF7 cells (53, 54) . Recently, it was reported that TNF can promote G 1 /S transition in vascular endothelial cells and facilitate the cell cycle activation induced by vascular endothelial growth factor (55) . Our findings suggest that these genes work together and play important roles in different cell cycle phases to control cell cycle checkpoints. However, the results should be interpreted with caution. As any model, CART has its own weakness. CART splits trees only by one variable and does not use combinations of variables. CART may have unstable tree structure. Small variations in the data might lead to radical changes in decision trees. This problem can be alleviated by using decision trees within an ensemble. In CART analysis, learning an optimal decision tree is based on the heuristic algorithms where the tree is optimal at each split locally. It may not be globally optimal. It helps by training multiple trees in an ensemble learner and randomly sampling samples with replacement. We acknowledge that CART analysis is an exploratory analysis. Prospective validations in independent studies are required to confirm the results of our studies.
To our knowledge, ours is the first study to examine the association of a large panel of tagging SNPs in cell cycle and DNA repair genes with age-associated CRC risk in people with Lynch syndrome. Other strengths of our study include the multigenic pathway-based approach, which helped us identify subgroups of individuals who differ significantly in risk profiles. Potentially, the SNPs identified may also influence risk for sporadic CRC as shown in our earlier studies where a cyclin D1 A870G SNP that modified age of CRC onset in Lynch syndrome mutation carriers (17) was also shown to increase sporadic CRC risk at a younger age (in people <60 years) (56) . Similarly, two other studies reported that the cyclin D1 A870G polymorphism was associated with increased CRC risk in younger patients within the Taiwanese population (57) and also increased risk for incident sporadic colorectal adenomas (58) . In our current study, we further validated the cyclin D1 A870G SNP, and although the P value was less than the significance level (P < 0.05), it did not meet the multiple testing threshold and so was not included in the top SNPs. Upon validation of our study results, future studies could be directed towards examining the influence of cell cycle-related modifiers of CRC risk as modifiers of non-syndromic (sporadic) CRC risk.
Recent genome-wide association studies (GWASs) have identified at least 15 common genetic susceptibility loci associated with CRC (59-61). Interestingly, six susceptibility loci map to genes involved in the transforming growth factor-beta (TGFβ) signaling pathway, including GREM1, BMP2, BMP4, SMAD7, RHPN2 and LAMA5. Our study focused on cell cycle-related genes. Among 10 significant loci, two of them map to genes involved in the TGFβ signaling pathway, TGFB1 and BCL2, respectively. The findings of our study together with the overrepresentation of TGFβ-related loci in the GWASs suggest that perturbation in the TGFβ signaling pathway plays a critical role in CRC susceptibility (62) .
The limitations of our study include the restriction of the population to non-Hispanic whites. Cooperative interinstitutional studies are needed to examine SNPs potentially associated with age of onset of CRC in other ethnic groups. Additionally, the frequency of adverse genotypes for some of the significant SNPs was low (<5%), and those results may be unstable. Furthermore, in our study we were not able to allow for the potential modifying effects of environmental risk factors on age-associated CRC risk. Factors such as smoking (63) (64) (65) , meat consumption and meat preparation (66) , overweight and obesity (67, 68) , oral contraceptive use (69), fruit consumption and dietary fiber intake (63) have been examined as potential modifiers of adenoma or CRC risk in people with Lynch syndrome. In particular, there is convincing evidence for smoking as a modifier of risk. However, we did not have complete smoking data from our study participants and therefore could not adjust for smoking or other environmental risk factors in the multivariable model. Another limitation of our study is lack of data for tumor site. We were unable to conduct analysis stratifying by rectal and colon cancer. Several GWASs have reported that there were notable site-specific differences in risk associated with some SNPs including rs3802842 at 11q23 and rs4939827 (SMAD7) (70-72), although Broderick et al. (73) did not observe differences by site.
In conclusion, we identified SNPs in 10 genes that were associated with earlier age of onset of CRC in non-Hispanic white patients with Lynch syndrome, and we applied a risk modeling approach to classify individuals into different risk groups on the basis of their genotypes. Ongoing, larger and pooled GWAS analyses as well as studies in other ethnic populations may help identify additional susceptibility alleles and together these may better classify CRC risk. Such classification may help refine the frequency and intensity of screening required for these at-risk subjects. Although our results were based on a large sample size, further validation of these findings is warranted in nonHispanic whites and in other ethnic groups. Supplementary Figures 1 and 2 can be found at http://carcin.oxfordjournals.org/
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